Antiviral Drugs Market By Drug Class (Nucleoside & Nucleotide Analogues, Protease Inhibitors, Integrase Inhibitors, Neuraminidase Inhibitors, Reverse Transcriptase Inhibitors, Fusion & Entry Inhibitors, Polymerase Inhibitors, and Others), By Indication (Human Immunodeficiency Virus (HIV), Hepatitis B, Hepatitis C, Influenza, Herpes Simplex Virus (HSV), Cytomegalovirus (CMV), Respiratory Syncytial Virus (RSV), COVID-19, and Others), By Route of Administration (Oral, Injectable, Topical, and Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Drug Type (Branded Drugs and Generic Drugs), By Age Group (Pediatric, Adult, and Geriatric), By Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026–2035

Published date: June 2026
Report ID: 97163
Number of Pages: 380
Format:

Fact Checked

Cite this Research

Table of Content
- 1. Research Methodology and Data Source
  - 1.1. Methodology/Research Approach
  - 1.2. Market Size Estimation
  - 1.3. Market Breakdown and Data Triangulation
  - 1.4. Data Sources
  - 1.5. Secondary Sources
  - 1.6. Primary Sources
- 2. Executive Summary
  - 2.1. Taxonomy
  - 2.2. Global Market Outlook
  - 2.3. Key Facts and Figures
  - 2.4. Major Players in Antiviral Drugs Market
- 3. Global Market Overview
  - 3.1. Industry Overview
  - 3.2. Segmental Overview
  - 3.3. Regional Overview
  - 3.4. Market Dynamics
    
    3.4.1. Drivers
    
    3.4.2. Restraints
    
    3.4.3. Opportunities
    
    3.4.4. Trends
  - 3.5. Regulatory Framework
  - 3.6. Opportunity Map Analysis
  - 3.7. Opportunity Orbits
  - 3.8. Market Investment Feasibility Index
  - 3.9. PESTLE Analysis
  - 3.10. PORTER’S Five Force Analysis
  - 3.11. Drivers & Restraints Impact Analysis
  - 3.12. Patient Journey Mapping
  - 3.13. Technological Landscape
  - 3.14. Product Life Cycle Analysis
  - 3.15. Value Chain Analysis
    
    3.15.1. List of Raw Material Suppliers
    
    3.15.2. List of Antiviral Drugs Manufacturers
    
    3.15.3. List of Dealer/Distributors
    
    3.15.4. List of Potential Customers
  - 3.16. Cost Structure Analysis
  - 3.17. Regional Market Share and BPS Analysis
- 4. Macro-economic Factors
- 5. Impact of Current Geopolitical Scenario
- 6. Global Antiviral Drugs Market Analysis and Forecast, By Drug Class
  - 6.1. Key Findings
  - 6.2. Global Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    6.2.1. Nucleoside & Nucleotide Analogues
    
    6.2.2. Protease Inhibitors
    
    6.2.3. Integrase Inhibitors
    
    6.2.4. Neuraminidase Inhibitors
    
    6.2.5. Reverse Transcriptase Inhibitors
    
    6.2.6. Fusion & Entry Inhibitors
    
    6.2.7. Polymerase
    
    6.2.8. Others
  - 6.3. Global Antiviral Drugs Market Attractiveness Analysis, By Drug Class
- 7. Global Antiviral Drugs Market Analysis and Forecast, By Indication
  - 7.1. Key Findings
  - 7.2. Global Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    7.2.1. Human Immunodeficiency Virus (HIV)
    
    7.2.2. Hepatitis B
    
    7.2.3. Hepatitis C
    
    7.2.4. Influenza
    
    7.2.5. Herpes Simplex Virus (HSV)
    
    7.2.6. Cytomegalovirus (CMV)
    
    7.2.7. Respiratory Syncytial Virus (RSV)
    
    7.2.8. COVID-19
    
    7.2.9. Others
  - 7.3. Global Antiviral Drugs Market Attractiveness Analysis, By Indication
- 8. Global Antiviral Drugs Market Analysis and Forecast, By Route of Administration
  - 8.1. Key Findings
  - 8.2. Global Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    8.2.1. Oral
    
    8.2.2. Injectable
    
    8.2.3. Topical
    
    8.2.4. Inhalation
  - 8.3. Global Antiviral Drugs Market Attractiveness Analysis, By Route of Administration
- 9. Global Antiviral Drugs Market Analysis and Forecast, By Distribution Channel
  - 9.1. Key Findings
  - 9.2. Global Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    9.2.1. Hospital Pharmacies
    
    9.2.2. Retail Pharmacies
    
    9.2.3. Online Pharmacies
  - 9.3. Global Antiviral Drugs Market Attractiveness Analysis, By Distribution Channel
- 10. Global Antiviral Drugs Market Analysis and Forecast, By Drug Type
  - 10.1. Key Findings
  - 10.2. Global Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    10.2.1. Branded Drugs
    
    10.2.2. Generic Drugs
  - 10.3. Global Antiviral Drugs Market Attractiveness Analysis, By Drug Type
  - 11. Global Antiviral Drugs Market Analysis and Forecast, By Age Group
  - 11.1. Key Findings
  - 11.2. Global Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
    
    11.2.1. Pediatric
    
    11.2.2. Adult
    
    11.2.3. Geriatric
  - 11.3. Global Antiviral Drugs Market Attractiveness Analysis, By Age Group
- 12. Global Antiviral Drugs Market Analysis and Forecast, By Region
  - 12.1. Key Findings
  - 12.2. Global Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Region, 2020-2035
    
    12.2.1. North America
    
    12.2.2. Europe
    
    12.2.3. Asia Pacific
    
    12.2.4. Middle East & Africa
    
    12.2.5. Latin America
  - 12.3. Global Antiviral Drugs Market Attractiveness Analysis, By Region
- 13. North America Antiviral Drugs Market Analysis and Forecast, 2020-2035
  - 13.1. Key Findings
  - 13.2. North America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  - 13.3. North America Antiviral Drugs Market Attractiveness Analysis, By Drug Class
  - 13.4. North America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
  - 13.5. North America Antiviral Drugs Market Attractiveness Analysis, By Indication
  - 13.6. North America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  - 13.7. North America Antiviral Drugs Market Attractiveness Analysis, By Route of Administration
  - 13.8. North America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  - 13.9. North America Antiviral Drugs Market Attractiveness Analysis, By Distribution Channel
  - 13.10. North America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  - 13.11. North America Antiviral Drugs Market Attractiveness Analysis, By Drug Type
  - 13.12. North America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
  - 13.13. North America Antiviral Drugs Market Attractiveness Analysis, By Age Group
  - 13.14. North America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  - 13.15. North America Antiviral Drugs Market Attractiveness Analysis, By Country
    
    13.15.1. The US Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    13.15.2. The US Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    13.15.3. The US Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    13.15.4. The US Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    13.15.5. The US Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    13.15.6. The US Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
    
    13.15.7. Canada Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    13.15.8. Canada Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    13.15.9. Canada Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    13.15.10. Canada Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    13.15.11. Canada Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    13.15.12. Canada Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
- 14. Europe Antiviral Drugs Market Analysis and Forecast, 2020-2035
  - 14.1. Key Findings
  - 14.2. Europe Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  - 14.3. Europe Antiviral Drugs Market Attractiveness Analysis, By Drug Class
  - 14.4. Europe Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
  - 14.5. Europe Antiviral Drugs Market Attractiveness Analysis, By Indication
  - 14.6. Europe Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  - 14.7. Europe Antiviral Drugs Market Attractiveness Analysis, By Route of Administration
  - 14.8. Europe Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  - 14.9. Europe Antiviral Drugs Market Attractiveness Analysis, By Distribution Channel
  - 14.10. Europe Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  - 14.11. Europe Antiviral Drugs Market Attractiveness Analysis, By Drug Type
  - 14.12. Europe Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
  - 14.13. Europe Antiviral Drugs Market Attractiveness Analysis, By Age Group
  - 14.14. Europe Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  - 14.15. Europe Antiviral Drugs Market Attractiveness Analysis, By Country
    
    14.15.1. Germany Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    14.15.2. Germany Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    14.15.3. Germany Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    14.15.4. Germany Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    14.15.5. Germany Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    14.15.6. Germany Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
    
    14.15.7. The U.K. Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    14.15.8. The U.K. Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    14.15.9. The U.K. Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    14.15.10. The U.K. Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    14.15.11. The U.K. Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    14.15.12. The U.K. Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
    
    14.15.13. France Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    14.15.14. France Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    14.15.15. France Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    14.15.16. France Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    14.15.17. France Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    14.15.18. France Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
    
    14.15.19. Spain Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    14.15.20. Spain Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    14.15.21. Spain Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    14.15.22. Spain Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    14.15.23. Spain Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    14.15.24. Spain Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
    
    14.15.25. Italy Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    14.15.26. Italy Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    14.15.27. Italy Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    14.15.28. Italy Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    14.15.29. Italy Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    14.15.30. Italy Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
    
    14.15.31. Russia & CIS Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    14.15.32. Russia & CIS Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    14.15.33. Russia & CIS Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    14.15.34. Russia & CIS Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    14.15.35. Russia & CIS Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    14.15.36. Russia & CIS Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
    
    14.15.37. Rest of Europe Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    14.15.38. Rest of Europe Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    14.15.39. Rest of Europe Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    14.15.40. Rest of Europe Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    14.15.41. Rest of Europe Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    14.15.42. Rest of Europe Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
- 15. Asia Pacific Antiviral Drugs Market Analysis and Forecast, 2020-2035
  - 15.1. Key Findings
  - 15.2. Asia Pacific Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  - 15.3. Asia Pacific Antiviral Drugs Market Attractiveness Analysis, By Drug Class
  - 15.4. Asia Pacific Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
  - 15.5. Asia Pacific Antiviral Drugs Market Attractiveness Analysis, By Indication
  - 15.6. Asia Pacific Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  - 15.7. Asia Pacific Antiviral Drugs Market Attractiveness Analysis, By Route of Administration
  - 15.8. Asia Pacific Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  - 15.9. Asia Pacific Antiviral Drugs Market Attractiveness Analysis, By Distribution Channel
  - 15.10. Asia Pacific Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  - 15.11. Asia Pacific Antiviral Drugs Market Attractiveness Analysis, By Drug Type
  - 15.12. Asia Pacific Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
  - 15.13. Asia Pacific Antiviral Drugs Market Attractiveness Analysis, By Age Group
  - 15.14. Asia Pacific Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  - 15.15. Asia Pacific Antiviral Drugs Market Attractiveness Analysis, By Country
    
    15.15.1. China Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    15.15.2. China Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    15.15.3. China Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    15.15.4. China Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    15.15.5. China Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    15.15.6. China Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
    
    15.15.7. India Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    15.15.8. India Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    15.15.9. India Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    15.15.10. India Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    15.15.11. India Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    15.15.12. India Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
    
    15.15.13. Japan Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    15.15.14. Japan Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    15.15.15. Japan Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    15.15.16. Japan Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    15.15.17. Japan Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    15.15.18. Japan Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
    
    15.15.19. South Korea Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    15.15.20. South Korea Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    15.15.21. South Korea Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    15.15.22. South Korea Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    15.15.23. South Korea Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    15.15.24. South Korea Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
    
    15.15.25. ASEAN Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    15.15.26. ASEAN Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    15.15.27. ASEAN Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    15.15.28. ASEAN Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    15.15.29. ASEAN Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    15.15.30. ASEAN Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
    
    15.15.31. Australia & New Zealand Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    15.15.32. Australia & New Zealand Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    15.15.33. Australia & New Zealand Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    15.15.34. Australia & New Zealand Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    15.15.35. Australia & New Zealand Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    15.15.36. Australia & New Zealand Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
    
    15.15.37. Rest of Asia Pacific Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    15.15.38. Rest of Asia Pacific Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    15.15.39. Rest of Asia Pacific Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    15.15.40. Rest of Asia Pacific Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    15.15.41. Rest of Asia Pacific Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    15.15.42. Rest of Asia Pacific Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
- 16. Middle East & Africa Antiviral Drugs Market Analysis and Forecast, 2020-2035
  - 16.1. Key Findings
  - 16.2. Middle East & Africa Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  - 16.3. Middle East & Africa Antiviral Drugs Market Attractiveness Analysis, By Drug Class
  - 16.4. Middle East & Africa Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
  - 16.5. Middle East & Africa Antiviral Drugs Market Attractiveness Analysis, By Indication
  - 16.6. Middle East & Africa Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  - 16.7. Middle East & Africa Antiviral Drugs Market Attractiveness Analysis, By Route of Administration
  - 16.8. Middle East & Africa Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  - 16.9. Middle East & Africa Antiviral Drugs Market Attractiveness Analysis, By Distribution Channel
  - 16.10. Middle East & Africa Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  - 16.11. Middle East & Africa Antiviral Drugs Market Attractiveness Analysis, By Drug Type
  - 16.12. Middle East & Africa Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
  - 16.13. Middle East & Africa Antiviral Drugs Market Attractiveness Analysis, By Age Group
  - 16.14. Middle East & Africa Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  - 16.15. Middle East & Africa Antiviral Drugs Market Attractiveness Analysis, By Country
    
    16.15.1. GCC Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    16.15.2. GCC Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    16.15.3. GCC Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    16.15.4. GCC Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    16.15.5. GCC Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    16.15.6. GCC Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
    
    16.15.7. South Africa Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    16.15.8. South Africa Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    16.15.9. South Africa Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    16.15.10. South Africa Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    16.15.11. South Africa Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    16.15.12. South Africa Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
    
    16.15.13. Rest of Middle East & Africa Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    16.15.14. Rest of Middle East & Africa Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    16.15.15. Rest of Middle East & Africa Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    16.15.16. Rest of Middle East & Africa Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    16.15.17. Rest of Middle East & Africa Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    16.15.18. Rest of Middle East & Africa Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
- 17. Latin America Antiviral Drugs Market Analysis and Forecast, 2020-2035
  - 17.1. Key Findings
  - 17.2. Latin America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  - 17.3. Latin America Antiviral Drugs Market Attractiveness Analysis, By Drug Class
  - 17.4. Latin America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
  - 17.5. Latin America Antiviral Drugs Market Attractiveness Analysis, By Indication
  - 17.6. Latin America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  - 17.7. Latin America Antiviral Drugs Market Attractiveness Analysis, By Route of Administration
  - 17.8. Latin America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  - 17.9. Latin America Antiviral Drugs Market Attractiveness Analysis, By Distribution Channel
  - 17.10. Latin America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  - 17.11. Latin America Antiviral Drugs Market Attractiveness Analysis, By Drug Type
  - 17.12. Latin America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
  - 17.13. Latin America Antiviral Drugs Market Attractiveness Analysis, By Age Group
  - 17.14. Latin America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  - 17.15. Latin America Antiviral Drugs Market Attractiveness Analysis, By Country
    
    17.15.1. Brazil Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    17.15.2. Brazil Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    17.15.3. Brazil Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    17.15.4. Brazil Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    17.15.5. Brazil Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    17.15.6. Brazil Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
    
    17.15.7. Mexico Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    17.15.8. Mexico Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    17.15.9. Mexico Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    17.15.10. Mexico Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    17.15.11. Mexico Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    17.15.12. Mexico Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
    
    17.15.13. Rest of Latin America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    17.15.14. Rest of Latin America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Indication, 2020-2035
    
    17.15.15. Rest of Latin America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    17.15.16. Rest of Latin America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    17.15.17. Rest of Latin America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Drug Type, 2020-2035
    
    17.15.18. Rest of Latin America Antiviral Drugs Market Size Value (US$ Bn) Forecast, By Age Group, 2020-2035
- 18. Competitive Landscape & Company Profiles
  - 18.1. Market Competition Scenario Analysis, By Company
  - 18.2. Competitor Landscape
  - 18.3. Company Share Analysis
  - 18.4. Company Profiles
    
    18.4.1. Gilead Sciences
    
    18.4.1.1. Company Details
    
    18.4.1.2. Business Overview
    
    18.4.1.3. Product Portfolio
    
    18.4.1.4. Financial Insights
    
    18.4.1.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    18.4.1.6. SWOT Analysis
    
    18.4.1.7. Geographic Footprint
    
    18.4.2. Pfizer Inc.
    
    18.4.2.1. Company Details
    
    18.4.2.2. Business Overview
    
    18.4.2.3. Product Portfolio
    
    18.4.2.4. Financial Insights
    
    18.4.2.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    18.4.2.6. SWOT Analysis
    
    18.4.2.7. Geographic Footprint
    
    18.4.3. Merck & Co. (MSD)
    
    18.4.3.1. Company Details
    
    18.4.3.2. Business Overview
    
    18.4.3.3. Product Portfolio
    
    18.4.3.4. Financial Insights
    
    18.4.3.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    18.4.3.6. SWOT Analysis
    
    18.4.3.7. Geographic Footprint
    
    18.4.4. Roche Holding AG
    
    18.4.4.1. Company Details
    
    18.4.4.2. Business Overview
    
    18.4.4.3. Product Portfolio
    
    18.4.4.4. Financial Insights
    
    18.4.4.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    18.4.4.6. SWOT Analysis
    
    18.4.4.7. Geographic Footprint
    
    18.4.5. Johnson & Johnson
    
    18.4.5.1. Company Details
    
    18.4.5.2. Business Overview
    
    18.4.5.3. Product Portfolio
    
    18.4.5.4. Financial Insights
    
    18.4.5.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    18.4.5.6. SWOT Analysis
    
    18.4.5.7. Geographic Footprint
    
    18.4.6. AbbVie Inc.
    
    18.4.6.1. Company Details
    
    18.4.6.2. Business Overview
    
    18.4.6.3. Product Portfolio
    
    18.4.6.4. Financial Insights
    
    18.4.6.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    18.4.6.6. SWOT Analysis
    
    18.4.6.7. Geographic Footprint
    
    18.4.7. Novartis AG
    
    18.4.7.1. Company Details
    
    18.4.7.2. Business Overview
    
    18.4.7.3. Product Portfolio
    
    18.4.7.4. Financial Insights
    
    18.4.7.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    18.4.7.6. SWOT Analysis
    
    18.4.7.7. Geographic Footprint
    
    18.4.8. Lonza Group AG
    
    18.4.8.1. Company Details
    
    18.4.8.2. Business Overview
    
    18.4.8.3. Product Portfolio
    
    18.4.8.4. Financial Insights
    
    18.4.8.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    18.4.8.6. SWOT Analysis
    
    18.4.8.7. Geographic Footprint
    
    18.4.9. Catalent, Inc.
    
    18.4.9.1. Company Details
    
    18.4.9.2. Business Overview
    
    18.4.9.3. Product Portfolio
    
    18.4.9.4. Financial Insights
    
    18.4.9.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    18.4.9.6. SWOT Analysis
    
    18.4.9.7. Geographic Footprint
    
    18.4.10. Cytiva (Danaher)
    
    18.4.10.1. Company Details
    
    18.4.10.2. Business Overview
    
    18.4.10.3. Product Portfolio
    
    18.4.10.4. Financial Insights
    
    18.4.10.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    18.4.10.6. SWOT Analysis
    
    18.4.10.7. Geographic Footprint
    
    18.4.11. Samsung Biologics
    
    18.4.11.1. Company Details
    
    18.4.11.2. Business Overview
    
    18.4.11.3. Product Portfolio
    
    18.4.11.4. Financial Insights
    
    18.4.11.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    18.4.11.6. SWOT Analysis
    
    18.4.11.7. Geographic Footprint
    
    18.4.12. Thermo Fisher Scientific
    
    18.4.12.1. Company Details
    
    18.4.12.2. Business Overview
    
    18.4.12.3. Product Portfolio
    
    18.4.12.4. Financial Insights
    
    18.4.12.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    18.4.12.6. SWOT Analysis
    
    18.4.12.7. Geographic Footprint
    
    18.4.13. Bayer AG
    
    18.4.13.1. Company Details
    
    18.4.13.2. Business Overview
    
    18.4.13.3. Product Portfolio
    
    18.4.13.4. Financial Insights
    
    18.4.13.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    18.4.13.6. SWOT Analysis
    
    18.4.13.7. Geographic Footprint
    
    18.4.14. Bristol Myers Squibb
    
    18.4.14.1. Company Details
    
    18.4.14.2. Business Overview
    
    18.4.14.3. Product Portfolio
    
    18.4.14.4. Financial Insights
    
    18.4.14.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    18.4.14.6. SWOT Analysis
    
    18.4.14.7. Geographic Footprint
    
    18.4.15. Other Key Players
    
    18.4.15.1. Company Details
    
    18.4.15.2. Business Overview
    
    18.4.15.3. Product Portfolio
    
    18.4.15.4. Financial Insights
    
    18.4.15.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    18.4.15.6. SWOT Analysis
    
    18.4.15.7. Geographic Footprint
List of Tables
- Table 1: Global Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 2: Global Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 3: Global Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 4: Global Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 5: Global Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 6: Global Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 7: Global Antiviral Drugs Market Value (US$ Bn), By Region, 2020-2035
- Table 8: North America Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 9: North America Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 10: North America Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 11: North America Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 12: North America Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 13: North America Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 14: North America Antiviral Drugs Market Value (US$ Bn), By Country, 2020-2035
- Table 15: The US Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 16: The US Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 17: The US Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 18: The US Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 19: The US Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 20: The US Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 21: Canada Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 22: Canada Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 23: Canada Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 24: Canada Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 25: Canada Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 26: Canada Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 27: Europe Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 28: Europe Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 29: Europe Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 30: Europe Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 31: Europe Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 32: Europe Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 33: Europe Antiviral Drugs Market Value (US$ Bn), By Country, 2020-2035
- Table 34: Germany Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 35: Germany Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 36: Germany Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 37: Germany Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 38: Germany Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 39: Germany Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 40: The U.K. Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 41: The U.K. Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 42: The U.K. Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 43: The U.K. Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 44: The U.K. Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 45: The U.K. Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 46: France Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 47: France Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 48: France Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 49: France Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 50: France Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 51: France Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 52: Spain Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 53: Spain Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 54: Spain Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 55: Spain Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 56: Spain Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 57: Spain Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 58: Italy Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 59: Italy Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 60: Italy Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 61: Italy Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 62: Italy Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 63: Italy Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 64: Russia & CIS Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 65: Russia & CIS Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 66: Russia & CIS Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 67: Russia & CIS Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 68: Russia & CIS Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 69: Russia & CIS Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 70: Rest of Europe Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 71: Rest of Europe Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 72: Rest of Europe Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 73: Rest of Europe Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 74: Rest of Europe Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 75: Rest of Europe Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 76: Asia Pacific Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 77: Asia Pacific Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 78: Asia Pacific Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 79: Asia Pacific Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 80: Asia Pacific Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 81: Asia Pacific Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 82: Asia Pacific Antiviral Drugs Market Value (US$ Bn), By Country, 2020-2035
- Table 83: China Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 84: China Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 85: China Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 86: China Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 87: China Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 88: China Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 89: India Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 90: India Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 91: India Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 92: India Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 93: India Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 94: India Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 95: Japan Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 96: Japan Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 97: Japan Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 98: Japan Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 99: Japan Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 100: Japan Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 101: South Korea Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 102: South Korea Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 103: South Korea Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 104: South Korea Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 105: South Korea Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 106: South Korea Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 107: ASEAN Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 108: ASEAN Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 109: ASEAN Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 110: ASEAN Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 111: ASEAN Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 112: ASEAN Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 113: Australia & New Zealand Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 114: Australia & New Zealand Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 115: Australia & New Zealand Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 116: Australia & New Zealand Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 117: Australia & New Zealand Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 118: Australia & New Zealand Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 119: Rest of Asia Pacific Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 120: Rest of Asia Pacific Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 121: Rest of Asia Pacific Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 122: Rest of Asia Pacific Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 123: Rest of Asia Pacific Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 124: Rest of Asia Pacific Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 125: Middle East & Africa Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 126: Middle East & Africa Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 127: Middle East & Africa Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 128: Middle East & Africa Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 129: Middle East & Africa Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 130: Middle East & Africa Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 131: Middle East & Africa Antiviral Drugs Market Value (US$ Bn), By Country, 2020-2035
- Table 132: GCC Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 133: GCC Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 134: GCC Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 135: GCC Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 136: GCC Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 137: GCC Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 138: South Africa Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 139: South Africa Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 140: South Africa Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 141: South Africa Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 142: South Africa Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 143: South Africa Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 144: Rest of Middle East & Africa Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 145: Rest of Middle East & Africa Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 146: Rest of Middle East & Africa Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 147: Rest of Middle East & Africa Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 148: Rest of Middle East & Africa Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 149: Rest of Middle East & Africa Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 150: Latin America Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 151: Latin America Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 152: Latin America Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 153: Latin America Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 154: Latin America Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 155: Latin America Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 156: Latin America Antiviral Drugs Market Value (US$ Bn), By Country, 2020-2035
- Table 157: Brazil Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 158: Brazil Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 159: Brazil Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 160: Brazil Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 161: Brazil Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 162: Brazil Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 163: Mexico Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 164: Mexico Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 165: Mexico Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 166: Mexico Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 167: Mexico Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 168: Mexico Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
- Table 169: Rest of Latin America Antiviral Drugs Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 170: Rest of Latin America Antiviral Drugs Market Value (US$ Bn), By Indication, 2020-2035
- Table 171: Rest of Latin America Antiviral Drugs Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 172: Rest of Latin America Antiviral Drugs Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 173: Rest of Latin America Antiviral Drugs Market Value (US$ Bn), By Drug Type, 2020-2035
- Table 174: Rest of Latin America Antiviral Drugs Market Value (US$ Bn), By Age Group, 2020-2035
List of Figures
- Figure 1: Global Antiviral Drugs Market Value (US$ Bn), 2020-2035
- Figure 2: Global Antiviral Drugs Market Value Share (%) Analysis, By Drug Class, 2025 & 2035
- Figure 3: Global Antiviral Drugs Market Value Share (%) Analysis, By Indication, 2025 & 2035
- Figure 4: Global Antiviral Drugs Market Value Share (%) Analysis, By Route of Administration, 2025 & 2035
- Figure 5: Global Antiviral Drugs Market Value Share (%) Analysis, By Distribution Channel, 2025 & 2035
- Figure 6: Global Antiviral Drugs Market Value Share (%) Analysis, By Drug Type, 2025 & 2035
- Figure 7: Global Antiviral Drugs Market Value Share (%) Analysis, By Age Group, 2025 & 2035
- Figure 8: Global Antiviral Drugs Market Value Share (%) Analysis, By Region, 2025 & 2035
- Figure 9: Global Antiviral Drugs Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
- Figure 10: Global Antiviral Drugs Market Attractiveness Analysis, By Drug Class
- Figure 11: Global Antiviral Drugs Market Value Share (%) Analysis, By Indication, 2020, 2025 and 2035
- Figure 12: Global Antiviral Drugs Market Attractiveness Analysis, By Indication
- Figure 13: Global Antiviral Drugs Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
- Figure 14: Global Antiviral Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 15: Global Antiviral Drugs Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
- Figure 16: Global Antiviral Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 17: Global Antiviral Drugs Market Value Share (%) Analysis, By Drug Type, 2020, 2025 and 2035
- Figure 18: Global Antiviral Drugs Market Attractiveness Analysis, By Drug Type
- Figure 19: Global Antiviral Drugs Market Value Share (%) Analysis, By Age Group, 2020, 2025 and 2035
- Figure 20: Global Antiviral Drugs Market Attractiveness Analysis, By Age Group
- Figure 21: Global Antiviral Drugs Market Value Share (%) Analysis, By Region, 2020, 2025 and 2035
- Figure 22: Global Antiviral Drugs Market Attractiveness Analysis, By Region
- Figure 23: North America Antiviral Drugs Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
- Figure 24: North America Antiviral Drugs Market Attractiveness Analysis, By Drug Class
- Figure 25: North America Antiviral Drugs Market Value Share (%) Analysis, By Indication, 2020, 2025 and 2035
- Figure 26: North America Antiviral Drugs Market Attractiveness Analysis, By Indication
- Figure 27: North America Antiviral Drugs Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
- Figure 28: North America Antiviral Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 29: North America Antiviral Drugs Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
- Figure 30: North America Antiviral Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 31: North America Antiviral Drugs Market Value Share (%) Analysis, By Drug Type, 2020, 2025 and 2035
- Figure 32: North America Antiviral Drugs Market Attractiveness Analysis, By Drug Type
- Figure 33: North America Antiviral Drugs Market Value Share (%) Analysis, By Age Group, 2020, 2025 and 2035
- Figure 34: North America Antiviral Drugs Market Attractiveness Analysis, By Age Group
- Figure 35: North America Antiviral Drugs Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
- Figure 36: North America Antiviral Drugs Market Attractiveness Analysis, By Country
- Figure 37: Europe Antiviral Drugs Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
- Figure 38: Europe Antiviral Drugs Market Attractiveness Analysis, By Drug Class
- Figure 39: Europe Antiviral Drugs Market Value Share (%) Analysis, By Indication, 2020, 2025 and 2035
- Figure 40: Europe Antiviral Drugs Market Attractiveness Analysis, By Indication
- Figure 41: Europe Antiviral Drugs Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
- Figure 42: Europe Antiviral Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 43: Europe Antiviral Drugs Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
- Figure 44: Europe Antiviral Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 45: Europe Antiviral Drugs Market Value Share (%) Analysis, By Drug Type, 2020, 2025 and 2035
- Figure 46: Europe Antiviral Drugs Market Attractiveness Analysis, By Drug Type
- Figure 47: Europe Antiviral Drugs Market Value Share (%) Analysis, By Age Group, 2020, 2025 and 2035
- Figure 48: Europe Antiviral Drugs Market Attractiveness Analysis, By Age Group
- Figure 49: Europe Antiviral Drugs Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
- Figure 50: Europe Antiviral Drugs Market Attractiveness Analysis, By Country
- Figure 51: Asia Pacific Antiviral Drugs Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
- Figure 52: Asia Pacific Antiviral Drugs Market Attractiveness Analysis, By Drug Class
- Figure 53: Asia Pacific Antiviral Drugs Market Value Share (%) Analysis, By Indication, 2020, 2025 and 2035
- Figure 54: Asia Pacific Antiviral Drugs Market Attractiveness Analysis, By Indication
- Figure 55: Asia Pacific Antiviral Drugs Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
- Figure 56: Asia Pacific Antiviral Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 57: Asia Pacific Antiviral Drugs Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
- Figure 58: Asia Pacific Antiviral Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 59: Asia Pacific Antiviral Drugs Market Value Share (%) Analysis, By Drug Type, 2020, 2025 and 2035
- Figure 60: Asia Pacific Antiviral Drugs Market Attractiveness Analysis, By Drug Type
- Figure 61: Asia Pacific Antiviral Drugs Market Value Share (%) Analysis, By Age Group, 2020, 2025 and 2035
- Figure 62: Asia Pacific Antiviral Drugs Market Attractiveness Analysis, By Age Group
- Figure 63: Asia Pacific Antiviral Drugs Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
- Figure 64: Asia Pacific Antiviral Drugs Market Attractiveness Analysis, By Country
- Figure 65: Middle East & Africa Antiviral Drugs Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
- Figure 66: Middle East & Africa Antiviral Drugs Market Attractiveness Analysis, By Drug Class
- Figure 67: Middle East & Africa Antiviral Drugs Market Value Share (%) Analysis, By Indication, 2020, 2025 and 2035
- Figure 68: Middle East & Africa Antiviral Drugs Market Attractiveness Analysis, By Indication
- Figure 69: Middle East & Africa Antiviral Drugs Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
- Figure 70: Middle East & Africa Antiviral Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 71: Middle East & Africa Antiviral Drugs Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
- Figure 72: Middle East & Africa Antiviral Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 73: Middle East & Africa Antiviral Drugs Market Value Share (%) Analysis, By Drug Type, 2020, 2025 and 2035
- Figure 74: Middle East & Africa Antiviral Drugs Market Attractiveness Analysis, By Drug Type
- Figure 75: Middle East & Africa Antiviral Drugs Market Value Share (%) Analysis, By Age Group, 2020, 2025 and 2035
- Figure 76: Middle East & Africa Antiviral Drugs Market Attractiveness Analysis, By Age Group
- Figure 77: Middle East & Africa Antiviral Drugs Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
- Figure 78: Middle East & Africa Antiviral Drugs Market Attractiveness Analysis, By Country
- Figure 79: Latin America Antiviral Drugs Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
- Figure 80: Latin America Antiviral Drugs Market Attractiveness Analysis, By Drug Class
- Figure 81: Latin America Antiviral Drugs Market Value Share (%) Analysis, By Indication, 2020, 2025 and 2035
- Figure 82: Latin America Antiviral Drugs Market Attractiveness Analysis, By Indication
- Figure 83: Latin America Antiviral Drugs Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
- Figure 84: Latin America Antiviral Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 85: Latin America Antiviral Drugs Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
- Figure 86: Latin America Antiviral Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 87: Latin America Antiviral Drugs Market Value Share (%) Analysis, By Drug Type, 2020, 2025 and 2035
- Figure 88: Latin America Antiviral Drugs Market Attractiveness Analysis, By Drug Type
- Figure 89: Latin America Antiviral Drugs Market Value Share (%) Analysis, By Age Group, 2020, 2025 and 2035
- Figure 90: Latin America Antiviral Drugs Market Attractiveness Analysis, By Age Group
- Figure 91: Latin America Antiviral Drugs Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
- Figure 92: Latin America Antiviral Drugs Market Attractiveness Analysis, By Country
- Gilead Sciences
- Pfizer Inc.
- Merck & Co. (MSD)
- Roche Holding AG
- Johnson & Johnson
- AbbVie Inc.
- Novartis AG
- Lonza Group AG
- Catalent, Inc.
- Cytiva (Danaher)
- Samsung Biologics
- Thermo Fisher Scientific
- Bayer AG
- Bristol Myers Squibb
- Other Key Players